Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CannaRoyalty Corp C.CRZ

Origin House is a growing cannabis product and brands company operating across key markets in the U.S. and Canada. The company delivers over 130 branded cannabis products to the licensed dispensaries. It provides distribution, manufacturing, cultivation and marketing services for its brand partners. The company operates through two operating segments, The Corporate segment derives income from non-operating investment and The California Operations segment engaged in cultivation, manufacturing, an


CSE:CRZ - Post by User

Post by toasted101on Sep 06, 2018 7:24pm
45 Views
Post# 28575975

Pistol Bay Clarifies MJ Exclusivity Agreement

Pistol Bay Clarifies MJ Exclusivity Agreement
Vancouver, B.C. – September 6, 2018: Pistol Bay Mining Inc. (TSX-V - PST; Frankfurt - OQS2, OTC/Pink Sheet symbol SLTFF) (“Pistol Bay” or the “Company’) would like to take this opportunity to clarify its news release issued September 5, 2018.  

At the present time, the Company has not entered into an agreement to market the nutraceutical products referenced in the news release issued yesterday.  The Company has entered into an exclusivity agreement with a private Ontario company (“Privco”), executed by the parties on September 4, 2018, that allows Pistol Bay to undertake due diligence on the products, the intellectual property surrounding the products and the market opportunities for both the foundational product, as well as new product applications containing cannabinoids.

The agreement restricts Privco from negotiating for the sale or licensing of the products to third parties for a period of 60 days.  The parties are at arm’s length.  No business or financial terms have been agreed to at this point and there can be no assurance that Pistol Bay will decide to proceed with a transaction following completion of due diligence, or that the parties will agree on financial or business terms.  If such an agreement is entered into, such transaction would likely constitute a change of business pursuant to the policies of the TSX Venture Exchange.  In such case trading will be halted pending the approval of such transaction by the TSX Venture Exchange.

The Company wishes to clarify certain information relating to the products which are the subject matter of the current due diligence being undertaken.  Privco has advised that it has invested $5.5 million to date in the development, and clinical testing of its foundational product, which has sold commercially since 1991.  This foundational product, primarily sold through multi-level marketing companies, is mainly a combination of botanicals that contain multiple molecules that contribute to delivering therapeutic effects, including stress reduction and anti-aging.  The foundational product holds an NPN (Natural Health Number) which was issued by Health Canada and Privco advises that retail sales of the product by third party licensees has totaled approximately US$500 million to date.

Privco has developed a product that combines its foundational product with CBD molecules.  CBD is a plant-based molecule that is getting a lot of attention recently for its many benefits including treating pain, anxiety, inflammation, and epilepsy.  Privco believes that CBD when combined with its foundational product could enhance the efficacy of the CBD. 

Privco is also developing a second product, a full spectrum soft gel, which will contain solely CBD.  Neither of these products have been made available for commercial sale and remain subject to further development and clinical trials. 

The Company also wishes to clarify that the statement from the September 5, 2018 news release, “We are unique worldwide in that our adaptogenic blend increases the bioavailability and bioefficacy of the cannabinoids significantly”, was meant to reference a statement put forward by Privco in their current marketing materials.  At present, Pistol Bay undertakes no activity in this line of business.

Investors are cautioned that until such time as a definitive transaction agreement is entered into, and a management information circular or filing statement is prepared in connection with such a transaction, any information released or received with respect to the potential transaction may not be accurate or complete and should not be relied upon.  Trading in the securities of Pistol Bay should be considered highly speculative.
The TSX Venture Exchange has in no way passed upon the merits of any potential transaction and has neither approved or disapproved the contents of this news release.

About Pistol Bay Mining Inc. 

Pistol Bay Mining Inc. is a diversified Junior Canadian Mineral Exploration Company with a focus on zinc and base metal properties in North America. The company is also actively pursuing the right opportunity in the Cannabis space looking to enhance shareholders value. For additional information please visit the Company website at www.pistolbaymininginc.com or contact Charles Desjardins at pistolbaymining@gmail.com.
 
On Behalf of the Board of Directors
PISTOL BAY MINING INC. 
"Charles Desjardins"                            
Charles Desjardins,
President and Director

<< Previous
Bullboard Posts
Next >>